Adherium Ltd (ADR) - Total Assets
Based on the latest financial reports, Adherium Ltd (ADR) holds total assets worth AU$4.16 Million AUD (≈ $2.94 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Adherium Ltd (ADR) net assets for net asset value and shareholders' equity analysis.
Adherium Ltd - Total Assets Trend (2012–2025)
This chart illustrates how Adherium Ltd's total assets have evolved over time, based on quarterly financial data.
Adherium Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Adherium Ltd's total assets of AU$4.16 Million consist of 96.7% current assets and 3.3% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 1.2% |
| Accounts Receivable | AU$80.71K | 2.3% |
| Inventory | AU$1.84 Million | 52.3% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$36.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Adherium Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Adherium Ltd stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Adherium Ltd's current assets represent 96.7% of total assets in 2025, an increase from 0.0% in 2012.
- Cash Position: Cash and equivalents constituted 1.2% of total assets in 2025, up from 0.0% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 11.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 52.3% of total assets.
Adherium Ltd Competitors by Total Assets
Key competitors of Adherium Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.12 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.00 Billion |
|
Lumos Diagnostics Holdings Ltd
AU:LDX
|
Australia | AU$20.81 Million |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
|
Ok Biotech Co Ltd
TW:4155
|
Taiwan | NT$3.89 Billion |
|
Promimic AB
ST:PRO
|
Sweden | Skr75.71 Million |
|
Memphasys Ltd
AU:MEM
|
Australia | AU$10.45 Million |
Adherium Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.82 | 1.41 | 0.72 |
| Quick Ratio | 0.50 | 0.84 | 0.58 |
| Cash Ratio | 0.00 | 0.11 | 0.46 |
| Working Capital | AU$-865.20K | AU$1.38 Million | AU$-2.08 Million |
Adherium Ltd - Advanced Valuation Insights
This section examines the relationship between Adherium Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.59 |
| Latest Market Cap to Assets Ratio | 2.10 |
| Asset Growth Rate (YoY) | -64.4% |
| Total Assets | AU$3.52 Million |
| Market Capitalization | $7.37 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Adherium Ltd's assets at a significant premium (2.10x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Adherium Ltd's assets decreased by 64.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Adherium Ltd (2012–2025)
The table below shows the annual total assets of Adherium Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$3.52 Million ≈ $2.49 Million |
-64.44% |
| 2024-06-30 | AU$9.89 Million ≈ $7.00 Million |
-22.03% |
| 2023-06-30 | AU$12.68 Million ≈ $8.97 Million |
+48.61% |
| 2022-06-30 | AU$8.53 Million ≈ $6.04 Million |
-49.92% |
| 2021-06-30 | AU$17.04 Million ≈ $12.06 Million |
+153.63% |
| 2020-06-30 | AU$6.72 Million ≈ $4.75 Million |
+199.38% |
| 2019-06-30 | AU$2.24 Million ≈ $1.59 Million |
-85.35% |
| 2018-06-30 | AU$15.32 Million ≈ $10.84 Million |
-38.94% |
| 2017-06-30 | AU$25.09 Million ≈ $17.75 Million |
-13.34% |
| 2016-06-30 | AU$28.95 Million ≈ $20.49 Million |
-22.07% |
| 2015-06-30 | AU$37.15 Million ≈ $26.29 Million |
+1231.67% |
| 2014-06-30 | AU$2.79 Million ≈ $1.97 Million |
-6.41% |
| 2014-03-31 | AU$2.98 Million ≈ $2.11 Million |
-17.83% |
| 2013-06-30 | AU$3.63 Million ≈ $2.57 Million |
+1732.22% |
| 2012-06-30 | AU$198.00K ≈ $140.10K |
-- |
About Adherium Ltd
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more